Beta Drugs (NSE:BETA) Days Sales Outstanding : 91.26 (As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Beta Drugs Days Sales Outstanding?

Beta Drugs's average Accounts Receivable for the six months ended in Sep. 2024 was ₹902 Mil. Beta Drugs's Revenue for the six months ended in Sep. 2024 was ₹1,803 Mil. Hence, Beta Drugs's Days Sales Outstanding for the six months ended in Sep. 2024 was 91.26.

The historical rank and industry rank for Beta Drugs's Days Sales Outstanding or its related term are showing as below:

NSE:BETA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 31 Med: 88.84 Max: 255.82
Current: 93.78

During the past 12 years, Beta Drugs's highest Days Sales Outstanding was 255.82. The lowest was 31.00. And the median was 88.84.

NSE:BETA's Days Sales Outstanding is ranked worse than
68.68% of 958 companies
in the Drug Manufacturers industry
Industry Median: 72.085 vs NSE:BETA: 93.78

Beta Drugs's Days Sales Outstanding increased from Sep. 2023 (90.71) to Sep. 2024 (91.26).

Beta Drugs Days Sales Outstanding Historical Data

The historical data trend for Beta Drugs's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beta Drugs Days Sales Outstanding Chart

Beta Drugs Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Days Sales Outstanding

Get a 7-Day Free Trial

114.47

103.42

78.48

86.71

87.61

Beta Drugs Semi-Annual Data
	Mar13	Mar14	Mar15	Mar16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Days Sales Outstanding	Get a 7-Day Free Trial															85.46	97.67	90.71	92.73	91.26

Competitive Comparison of Beta Drugs's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Beta Drugs's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beta Drugs's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beta Drugs's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Beta Drugs's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Beta Drugs Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Beta Drugs's Days Sales Outstanding for the fiscal year that ended in Mar. 2024 is calculated as

	Days Sales Outstanding (A: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (627.227	+	792.399)	/	2 )	/	2957.138	*	365
=	709.813					/	2957.138	*	365
=	87.61

Beta Drugs's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding (Q: Sep. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2024 )	+	Accounts Receivable (A: Sep. 2024 ))	/	count )	/	Revenue (A: Sep. 2024 )	*	Days in Period
=	( (792.399	+	1010.811)	/	2 )	/	1803.034	*	365 / 2
=	901.605					/	1803.034	*	365 / 2
=	91.26

Beta Drugs (NSE:BETA) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Beta Drugs Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Beta Drugs's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Beta Drugs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beta Drugs Ltd (NSE:BETA) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

N/A

Address

SCO-184, First Floor, Sector-5, Panchkula, HR, IND, 134114

Website

https://www.betadrugslimited.com

Beta Drugs Ltd operates in the pharmaceutical industry. The company manufactures and sells Oncology products in the form of tablets, capsules, oral formulations, and injections. It sells the products in India and also exports them to other countries of which key revenue is derived from the sales made in India.

Beta Drugs Headlines

No Headlines